Galectin Therapeutics Inc. · NASDAQ:GALT
Richard E. Uihlein reported a 49.30% stake in Galectin Therapeutics Inc. (Schedule 13D/A)
Event Jul 31, 2026 · Filed Aug 4, 2026
Richard E. Uihlein reported a 49.30% stake in Galectin Therapeutics Inc., 54,673,646 shares, with active intent on Jul 31, 2026. Filed Aug 4, 2026 (Schedule 13D/A).
- Stake
- 49.30%
- Shares
- 54,673,646
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Richard E. Uihlein | 49.30% | 54,673,646 |